Developer docs
API playgroundTry for free, no card

Search company profiles

MSI Reproductive Choices

Full company profile

uuid000tup6

Namestring
MSI Reproductive Choices
Legal namestring
MSI Reproductive Choices
Websiteurl
msichoices.org
Company typeenum
Private
Founded yearint
1976
Descriptiontext

MSI Reproductive Choices is a London-headquartered non-profit organisation, registered as a charity (no. 265543) and company limited by guarantee in England and Wales, that provides contraception, safe abortion and broader reproductive healthcare services across 36 country programmes in low- and middle-income countries. Founded in 1976, the organisation operates with 9,153 team members and reached an estimated 27.8 million people with life-changing healthcare in 2025, including over 100,000 women per day. Service delivery is structured around three core lines — Abortion Care, Contraception and Broader Healthcare — supported by programmatic priorities in gender equality, adolescent support, humanitarian aid, self-managed health, health system strengthening, and climate resilience.

The operational model is field-delivery-led: clinical and outreach services are executed by country-based teams and embedded into government health systems and civil-society partner networks. Funding flows from charitable donations, institutional grants, and partnerships with national governments and development organisations, with no publicly disclosed pricing. MSI's principal proprietary technology asset is the Impact 2 Model, a peer-reviewed modelling methodology used to translate financial inputs into projected health, demographic and economic outcomes; the organisation also operates a web-based Impact Investment Calculator that applies this methodology for donor-facing impact reporting.

Commercially, MSI is best understood as a global health services non-profit whose "customers" are end-beneficiaries (women and girls), institutional donor partners, and host-country governments — with the latter two being the de facto revenue counterparties. The organisation's strategic positioning is anchored in 50 years of brand credibility, an on-the-ground distribution footprint spanning 36 jurisdictions, and a peer-reviewed evidence platform increasingly relevant in competitive SRHR grant environments.

Short descriptiontext

MSI Reproductive Choices is a London-headquartered global nonprofit delivering contraception, abortion care and broader reproductive healthcare across 36 countries, reaching 27.8 million people in 2025 through 9,153 staff and government and civil-society partnerships.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
reproductive health services, contraception services, abortion care, sexual health programs, maternal healthcare
Industry5 codes
1Family Planning & Contraception (Including Abortion Care)
CodeHLAKAJAGPrimaryYes
2Sexual & Reproductive Health & Family Planning (SRH/FP) Programs
CodeBPADAIADPrimaryNo
3Obstetrics & Gynecology (OB/GYN) Clinics
CodeHLAFAJAAPrimaryNo
4Contraception & Family Planning Telehealth (birth control, counseling, follow-up)
CodeHLALAHABPrimaryNo
5Women’s Health & Contraception Prescribing + Pharmacy Delivery Platforms
CodeHLALAIAIPrimaryNo
NAICS code2 codes
  • Family Planning Centers621410
  • Social Assistance624
SIC code2 codes
  • Services-Social Services8300
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Reproductive Healthcare Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Donations and Charitable Funding
TypeSubscription Recurring
Description

As a registered charity in England and Wales (charity number 265543), MSI Reproductive Choices operates primarily through donations, charitable funding, and partnerships with governments and development organisations. In 2025, MSI supported 27.8 million people across 36 country programmes through these funding mechanisms.

msichoices.org
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

MSI Reproductive Choices provides contraception and safe abortion services, supplemented by broader reproductive healthcare, to women and girls across 36 low- and middle-income countries through branch offices, field teams, and partnerships with governments and civil society organisations. In 2025 the organisation supported 27.8 million people with life-changing healthcare, delivering services free at the point of care via donor- and government-funded programmes.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 27.8 million people supported with life-changing healthcare in 2025
+2 more records
Product overview1 text field

MSI Reproductive Choices provides a portfolio of reproductive healthcare services across 36 countries through three core service lines: Abortion Care, Contraception, and Broader Healthcare. The organization operates field programs focused on Gender Equality, Adolescent Support, Leave No One Behind (serving underserved communities), Self-Managed Health, Health System Strengthening, Humanitarian Aid, and Climate Resilience. MSI also offers an Impact Investment Calculator tool that uses the proprietary Impact 2 peer-reviewed methodology to help donors and partners measure the outcomes of their investments in reproductive health services.

Product and service4 records
1Abortion Care
CategoryCore service
Description

Safe abortion services providing women with reproductive choice and access to legal termination of pregnancy, delivered through clinics and field teams across 36 countries.

2Contraception
CategoryCore service
Description

Contraceptive services and commodities enabling women to plan their families and choose when to have children, delivered across 36 country programmes.

3Broader Healthcare
4Impact Investment Calculator
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Governments and civil society organisations
Strategic tierCoreTypeStrategic or Co-development Partner
Description

MSI operates through branch offices and affiliates in 36 jurisdictions and works in partnership with governments, civil society organisations and implementing partners to deliver sexual and reproductive healthcare services. These partnerships are central to MSI's service delivery model across low- and middle-income countries.

msichoices.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

A non-profit working in low- and middle-income countries to improve sexual and reproductive health, including contraception and safe abortion care. Comparable to MSI in service portfolio, partnership model, and geographic focus on SRH in developing-country health systems.

2Ipas
TypeDirect peer
Description

A global non-profit dedicated to expanding access to safe abortion and contraception, working through health system partnerships in Africa, Asia, and Latin America. Closely comparable to MSI in service mix, geographic focus, and partnership-driven delivery model.

TypeDirect peer
Description

An international non-profit conducting research and delivering programmes on sexual and reproductive health, including contraception and HIV. Comparable to MSI in SRH focus and global footprint, with additional emphasis on research and product development.

TypeDirect peer
Description

A global sexual and reproductive health non-profit operating in more than 15 countries, focused on contraception, family planning, and safe abortion. Comparable to MSI in mission, multi-country field delivery, and emphasis on underserved populations.

TypeEmerging player
Description

A global advocacy and partnership organisation focused on gender equality and the health and rights of girls and women, including sexual and reproductive health and rights. Comparable to MSI in mission and SRH/advocacy focus, with more emphasis on advocacy and convening than direct service delivery.

TypeDirect peer
Description

A global non-profit federation delivering sexual and reproductive health services across more than 120 countries. Directly comparable to MSI as a multi-country SRH provider with a similar government-partnership and clinic-based delivery model focused on contraception and abortion care.

TypeDirect peer
Description

A non-profit affiliated with Johns Hopkins University that partners with governments to deliver reproductive, maternal, and family health services globally. Comparable to MSI in government-partnership model, multi-country footprint, and focus on family planning and reproductive health.

TypeDirect peer
Description

A research and implementation organisation focused on expanding access to safe abortion and reproductive health technologies globally. Comparable to MSI in abortion-care focus and low- and middle-income country delivery, though smaller in scale.

TypeDirect peer
Description

One of the world's largest reproductive health providers, offering contraception, abortion, and broader sexual health services. Comparable to MSI in service portfolio and mission, though focused primarily on the US market rather than low- and middle-income countries.

TypeDirect peer
Description

A non-profit that increases access to contraception and safe abortion through social marketing and service delivery across more than 90 countries. Directly comparable to MSI in product focus (contraception and abortion), multi-country delivery model, and focus on low- and middle-income markets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MSI Reproductive Choices

Reproductive Healthcare Servicesmsichoices.org

MSI Reproductive Choices is a London-headquartered global nonprofit delivering contraception, abortion care and broader reproductive healthcare across 36 countries, reaching 27.8 million people in 2025 through 9,153 staff and government and civil-society partnerships.

What MSI Reproductive Choices does

MSI Reproductive Choices is a London-headquartered non-profit organisation, registered as a charity (no. 265543) and company limited by guarantee in England and Wales, that provides contraception, safe abortion and broader reproductive healthcare services across 36 country programmes in low- and middle-income countries. Founded in 1976, the organisation operates with 9,153 team members and reached an estimated 27.8 million people with life-changing healthcare in 2025, including over 100,000 women per day. Service delivery is structured around three core lines — Abortion Care, Contraception and Broader Healthcare — supported by programmatic priorities in gender equality, adolescent support, humanitarian aid, self-managed health, health system strengthening, and climate resilience.

The operational model is field-delivery-led: clinical and outreach services are executed by country-based teams and embedded into government health systems and civil-society partner networks. Funding flows from charitable donations, institutional grants, and partnerships with national governments and development organisations, with no publicly disclosed pricing. MSI's principal proprietary technology asset is the Impact 2 Model, a peer-reviewed modelling methodology used to translate financial inputs into projected health, demographic and economic outcomes; the organisation also operates a web-based Impact Investment Calculator that applies this methodology for donor-facing impact reporting.

Commercially, MSI is best understood as a global health services non-profit whose "customers" are end-beneficiaries (women and girls), institutional donor partners, and host-country governments — with the latter two being the de facto revenue counterparties. The organisation's strategic positioning is anchored in 50 years of brand credibility, an on-the-ground distribution footprint spanning 36 jurisdictions, and a peer-reviewed evidence platform increasingly relevant in competitive SRHR grant environments.

MSI Reproductive Choices firmographics

Firmographics
Name
MSI Reproductive Choices
Legal name
MSI Reproductive Choices
Website
https://msichoices.org
Company type
Private
Founded year
1976
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
MSI Reproductive Choices is a London-headquartered global nonprofit delivering contraception, abortion care and broader reproductive healthcare across 36 countries, reaching 27.8 million people in 2025 through 9,153 staff and government and civil-society partnerships.
Ownership category
akta.pro rank

MSI Reproductive Choices industry classification

Industry
Product category
Reproductive Healthcare Services
NAICS
Family Planning Centers (621410), Social Assistance (624)
SIC
Services-Social Services (8300), Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro primary industry
Family Planning & Contraception (Including Abortion Care) (HLAKAJAG)
akta.pro secondary industries
Sexual & Reproductive Health & Family Planning (SRH/FP) Programs (BPADAIAD), Obstetrics & Gynecology (OB/GYN) Clinics (HLAFAJAA), Contraception & Family Planning Telehealth (birth control, counseling, follow-up) (HLALAHAB), Women’s Health & Contraception Prescribing + Pharmacy Delivery Platforms (HLALAIAI)

Keywords

  • Reproductive health services
  • Contraception services
  • Abortion care
  • Sexual health programs
  • Maternal healthcare

Where MSI Reproductive Choices is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

MSI Reproductive Choices business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

  1. Donations and Charitable Funding: As a registered charity in England and Wales (charity number 265543), MSI Reproductive Choices operates primarily through donations, charitable funding, and partnerships with governments and development organisations. In 2025, MSI supported 27.8 million people across 36 country programmes through these funding mechanisms.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

MSI Reproductive Choices product offering

Product offering

Core offering

MSI Reproductive Choices provides contraception and safe abortion services, supplemented by broader reproductive healthcare, to women and girls across 36 low- and middle-income countries through branch offices, field teams, and partnerships with governments and civil society organisations. In 2025 the organisation supported 27.8 million people with life-changing healthcare, delivering services free at the point of care via donor- and government-funded programmes.

Product overview

MSI Reproductive Choices provides a portfolio of reproductive healthcare services across 36 countries through three core service lines: Abortion Care, Contraception, and Broader Healthcare. The organization operates field programs focused on Gender Equality, Adolescent Support, Leave No One Behind (serving underserved communities), Self-Managed Health, Health System Strengthening, Humanitarian Aid, and Climate Resilience. MSI also offers an Impact Investment Calculator tool that uses the proprietary Impact 2 peer-reviewed methodology to help donors and partners measure the outcomes of their investments in reproductive health services.

Differentiator

Problem solved

Functional benefit

Products and services

  • Abortion Care Safe abortion services providing women with reproductive choice and access to legal termination of pregnancy, delivered through clinics and field teams across 36 countries.
  • Contraception Contraceptive services and commodities enabling women to plan their families and choose when to have children, delivered across 36 country programmes.
  • Broader Healthcare
  • Impact Investment Calculator

Quantifiable outcome

  • 27.8 million people supported with life-changing healthcare in 2025
  • +2 more outcomes

Companies that use MSI Reproductive Choices

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles2 records

MSI Reproductive Choices technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

MSI Reproductive Choices partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Governments and civil society organisationscoreStrategic or Co-development PartnerMSI operates through branch offices and affiliates in 36 jurisdictions and works in partnership with governments, civil society organisations and implementing partners to deliver sexual and reproductive healthcare services. These partnerships are central to MSI's service delivery model across low- and middle-income countries.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

MSI Reproductive Choices competitors and assessment

Company assessment

Direct peers

  • EngenderHealth: A non-profit working in low- and middle-income countries to improve sexual and reproductive health, including contraception and safe abortion care. Comparable to MSI in service portfolio, partnership model, and geographic focus on SRH in developing-country health systems.
  • Ipas: A global non-profit dedicated to expanding access to safe abortion and contraception, working through health system partnerships in Africa, Asia, and Latin America. Closely comparable to MSI in service mix, geographic focus, and partnership-driven delivery model.
  • Population Council: An international non-profit conducting research and delivering programmes on sexual and reproductive health, including contraception and HIV. Comparable to MSI in SRH focus and global footprint, with additional emphasis on research and product development.
  • Pathfinder International: A global sexual and reproductive health non-profit operating in more than 15 countries, focused on contraception, family planning, and safe abortion. Comparable to MSI in mission, multi-country field delivery, and emphasis on underserved populations.
  • International Planned Parenthood Federation (IPPF): A global non-profit federation delivering sexual and reproductive health services across more than 120 countries. Directly comparable to MSI as a multi-country SRH provider with a similar government-partnership and clinic-based delivery model focused on contraception and abortion care.
  • Jhpiego: A non-profit affiliated with Johns Hopkins University that partners with governments to deliver reproductive, maternal, and family health services globally. Comparable to MSI in government-partnership model, multi-country footprint, and focus on family planning and reproductive health.
  • Gynuity Health Projects: A research and implementation organisation focused on expanding access to safe abortion and reproductive health technologies globally. Comparable to MSI in abortion-care focus and low- and middle-income country delivery, though smaller in scale.
  • Planned Parenthood Federation of America: One of the world's largest reproductive health providers, offering contraception, abortion, and broader sexual health services. Comparable to MSI in service portfolio and mission, though focused primarily on the US market rather than low- and middle-income countries.
  • DKT International: A non-profit that increases access to contraception and safe abortion through social marketing and service delivery across more than 90 countries. Directly comparable to MSI in product focus (contraception and abortion), multi-country delivery model, and focus on low- and middle-income markets.

Emerging players

  • Women Deliver: A global advocacy and partnership organisation focused on gender equality and the health and rights of girls and women, including sexual and reproductive health and rights. Comparable to MSI in mission and SRH/advocacy focus, with more emphasis on advocacy and convening than direct service delivery.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

MSI Reproductive Choices social profiles

Digital presence

MSI Reproductive Choices financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MSI Reproductive Choices leadership team

Management profile

Number of profiles

Profiles3 records

MSI Reproductive Choices funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MSI Reproductive Choices M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MSI Reproductive Choices

What does MSI Reproductive Choices do?

MSI Reproductive Choices provides contraception and safe abortion services, supplemented by broader reproductive healthcare, to women and girls across 36 low- and middle-income countries through branch offices, field teams, and partnerships with governments and civil society organisations. In 2025 the organisation supported 27.8 million people with life-changing healthcare, delivering services free at the point of care via donor- and government-funded programmes.

Is MSI Reproductive Choices a public or private company?

MSI Reproductive Choices is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was MSI Reproductive Choices founded?

MSI Reproductive Choices was founded in 1976. It employs 5,001 to 10,000 people.

Where is MSI Reproductive Choices based?

MSI Reproductive Choices is headquartered in London, United Kingdom, in the Europe region.

How does MSI Reproductive Choices make money?

One revenue line is on record: donations and Charitable Funding.

Who are MSI Reproductive Choices's main competitors?

Direct peers on record are EngenderHealth, Ipas, Population Council, Pathfinder International, International Planned Parenthood Federation (IPPF), Jhpiego, Gynuity Health Projects, Planned Parenthood Federation of America and DKT International. Women Deliver is listed as an emerging player.

Does MSI Reproductive Choices have an API?

No public API is recorded for MSI Reproductive Choices.

What industry is MSI Reproductive Choices in?

MSI Reproductive Choices's product category is Reproductive Healthcare Services. Its primary akta.pro industry code is HLAKAJAG, Family Planning & Contraception (Including Abortion Care), with a secondary code of BPADAIAD, Sexual & Reproductive Health & Family Planning (SRH/FP) Programs. Its NAICS code is 621410 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AP NewsThe pressure to have baby boys can harm African mothers’ healthCultural pressure to have sons in Congo's Luba tribe forces women to keep trying, endangering their health. Congo accounts for 70% of global maternal deaths, with 180,000 pregnancy deaths annually. A five-year plan aims to improve family planning access by 2026.The IndependentTrump administration refuses to distribute up to $10m in contraceptives bought as aidSecretary of State Marco Rubio told Congress that the Trump administration will not distribute nearly $10 million worth of contraceptives purchased by USAID, which are sitting in a Belgian warehouse and approaching expiry, intended for low-income countries in sub-Saharan Africa before the aid freeze. Reproductive health organizations condemned the decision, warning of rising unintended pregnancies, unsafe abortions, and maternal deaths, with 14 of 16 African countries where MSI Reproductive Choices operates reporting risk of running out of at least one contraception method. The commodity funding gap for 2026 stands at $186 million across 54 countries, with 65 percent concentrated in DRC, Ethiopia, Kenya, Madagascar, Malawi, Nigeria, Tanzania, Uganda, Rwanda and Zambia.Global NewsCarney urged to take action amid Trump’s abortion ‘gag rule’ for developing countries - NationalCanadian aid groups are urging Prime Minister Mark Carney to assemble an international coalition to defend sexual health and reproductive rights programming, as the Trump administration's expanded Mexico City Policy bars U.S. funding from groups providing abortion services, LGBTQ+ advocacy, or gender-affirming care. MSI Reproductive Choices reports a 20 percent increase in demand for sexual health services since Trump's return to office, while aid organizations warn the policy is fragmenting the global health system and forcing developing countries to make impossible funding choices. The Canadian government stated it will continue advocating for gender equality through multilateral bodies including the G7, G20, and United Nations.The GuardianNine in 10 UK voters across parties support right to abortion, poll findsYouGov polling commissioned by MSI Reproductive Choices found that nine in 10 UK voters across all major parties support the right to access abortion, with support ranging from 86% among Reform voters to 95% among Green voters. The survey, conducted to mark MSI Reproductive Choices' 50th anniversary, also found that nearly one in five people think abortion access could be reduced in the UK, rising to more than a quarter of 18- to 25-year-olds, who cited concerns about developments in the US and the rise of the far right. MSI Reproductive Choices stated that the findings demonstrate abortion is a mainstream, openly discussed part of life, with one in three women having an abortion in her lifetime.CNBC$9.7 million of U.S.-funded contraceptives for poor nations to be burned in France: ReutersThe U.S. State Department has decided to incinerate $9.7 million worth of contraceptives funded for poor nations, currently stored in a warehouse in Geel, Belgium, spending $167,000 to truck the supplies to a medical waste facility in France for destruction. The decision follows President Trump's freeze on foreign aid in January and the subsequent shutdown of USAID, with the administration rejecting offers from UNFPA and MSI Reproductive Choices to either purchase or redistribute the supplies to countries in need. Lawmakers have introduced two bills to prevent the destruction, but aid groups warn the move will increase unsafe abortions across sub-Saharan Africa, where millions of women relied on USAID for contraception access.ForbesFor Impact, Invest In ContraceptionA paid brand contributor post from MSI Reproductive Choices argues that funding contraception is among the highest-return investments for global development, citing a Copenhagen Consensus Center finding of $120 in benefits per dollar spent. The piece cites 257 million women wanting to avoid pregnancy without modern contraception, and that a 0.7% annual rise in use would prevent 7,000 infant and child deaths and 600 maternal deaths by 2030.PR NewswireMedicines360, MSI Reproductive Choices and MSK Announce Launch of Avibela® Hormonal Intrauterine Device in KenyaMedicines360, MSI Reproductive Choices, and Marie Stopes Kenya announced the launch of AVIBELA (levonorgestrel-releasing intrauterine system) 52 mg, a hormonal intrauterine device, in Kenya on August 2, 2021. This marks the third African launch of the device, following introductions in Madagascar and Zambia. Marie Stopes Kenya will distribute and market the product at a reduced price compared to prior Kenyan pricing, while providing training to healthcare providers across the country.